Psy115 - A Cost-Effectiveness Analysis of Raasi – Enabling Patiromer for the Treatment of Hyperkalemia in Austria

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2690
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Puk17 - A Cost-Effectiveness Analysis of Raasi – Enabling Patiromer for the Treatment of Hyperkalemia in Sweden

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients With Hyperkalemia

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2018English

Cost-Effectiveness Analysis of Amfepramone (Diethylpropion) for the Obesity Treatment in Mexico

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Effectiveness of Sodium Polystyrene Sulfonate for Short-Term Treatment of Hyperkalemia

Canadian Journal of Hospital Pharmacy
PharmacologyPharmacy
2015English

P357 Cost-Effectiveness Analysis for Treatment of Visceral Leishmaniasis in Armenia

2019English

Cost-Effectiveness Analysis of Lurasidone and Olanzapine in the Treatment of Schizophrenia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Vonoprazan Versus Lansoprazole for the Initial Treatment of Reflux Esophagitis: A Cost-Effectiveness Analysis in Japan

Internal Medicine
Internal MedicineMedicine
2019English

Cost-Effectiveness Analysis of Coil Embolization Treatment for Unruptured Cerebral Aneurysm

Surgery for Cerebral Stroke
2019English

Daratumumab vs. Pomalidomide for the Treatment of Relapsed/Refractory Multiple Myeloma: A Cost‐effectiveness Analysis

American Journal of Hematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy